A naukri.com initiative
Bioengineer
1w
109
Image Credit: Bioengineer
Study Reveals Bowel Impact of Fatal Neurodegenerative Disease in Children
- Gene therapy may serve as an effective treatment for gastrointestinal (GI) symptoms associated with Batten disease, a rare and devastating neurodegenerative disorder affecting children.
- Children suffering from Batten disease experience not only neurological decline but also debilitating GI complications that severely impact their daily lives.
- Treating mouse models of Batten disease with gene therapy could save enteric neurons from degeneration, thereby alleviating gastrointestinal dysfunction.
- Batten disease is characterized by a deficiency of a crucial enzyme responsible for breaking down cellular waste, leading to accumulation and progressive neuronal loss in both the brain and the enteric nervous system.
- Dr. Cooper’s work emphasizes that the enteric nervous system, which comprises around half a billion neurons, deserves focused attention as it plays a crucial role in regulating bowel movement and other essential digestive functions.
- Collaborating in this endeavor is Dr. Robert O. Heuckeroth, a pediatric gastroenterologist deeply invested in exploring the relationship between the enteric nervous system and Batten disease.
- The satisfaction of the study lies in its robust patient-focused methodology, paving the way for future research that is more aligned with patient needs and experiences.
- Dr. Cooper’s research shines a light on its application to the enteric nervous system, breaking new ground in this domain.
- The potential to administer gene therapy to correct enzyme deficiencies in both the brain and bowel signals a transformative shift in treating complex cases of Batten disease.
- The researchers have indicated that their findings could inform treatment strategies for other lysosomal storage disorders characterized by similar enzyme deficiencies, such as mucopolysaccharidoses.
Read Full Article
6 Likes
For uninterrupted reading, download the app